Medical wealth management firms are benefiting from higher net

Medical wealth management firms are benefiting from higher net interest margins amid the Fed’s “pause” stance on rate hikes, prompting strategic equity allocations into medical REITs and private biotech ventures. Analysts at JPMorgan project an 8% YoY growth in sector-managed AUM by year-end "I was staying with Desmond and many other Guinnesses at Leixlip," Lowell recalled. "We were halfheartedly watching Downton Abbey , and I thought, Oh, our family is so much more interesting and eccentric ." This is bolstered by the government’s wider announcement of a £54m fund to ‘attract world-leading researchers and innovators ’ 2 , and through initiatives like the Mansion House Accord, which together help provide a stronger framework for meaningful investment. With the S&P Healthcare Sector ETF flat in May, medical wealth management funds have outperformed, offering investors both yield and growth exposure. Morningstar’s latest report highlights a 12-month forward return potential of 7–10% for diversified portfolios in this space.